Build Strength as You Age Without Letting Training Wear You Down
Peter Attia and Jeff Cavaliere discuss balancing hard training, recovery, and exercise selection to keep building strength as you age.
1,025 articles
Peter Attia and Jeff Cavaliere discuss balancing hard training, recovery, and exercise selection to keep building strength as you age.
Peter Attia is less bullish on rapamycin for longevity, citing unresolved dosing questions that complicate its use in humans.
Noam Sobel explores how odors influence social behavior and hormones, plus the promise—and limits—of detecting disease through body odors.
Ross Edgley discusses shifting motivations, managing fatigue, and building resilience—and why extreme endurance stories are not clinical evidence.
Andrew Huberman explains how to build a supplement protocol around your needs, diet and budget, and why behavior and nutrition come first.
Layne Norton challenges meal-frequency myths with trials showing that one daily meal can worsen hunger and cardiometabolic markers.
Peter Attia and Siddhartha Mukherjee discuss cancer risk, hyperinsulinemia, KRAS inhibitors, CAR T therapy and why aging may be a problem of regenerative failure.
Neurosurgeon Matthew MacDougall explains brain implants for paralysis, surgical safety, and why cognitive enhancement remains a future possibility.
After 400 episodes, Peter Attia explains how his views on keto, fasting, metformin, rapamycin, cancer screening and exercise have changed.
Norton reports a 675 × 6 deadlift set at 44. It highlights strength in middle age, but one performance cannot establish health benefits.
Max Lugavere hosts a conversation on why ADHD is underdiagnosed in women, covering hormones, nutrition, exercise, sleep, digital distraction, and saffron research.
Layne Norton breaks down a viral sweetener study, separating lab-model limitations from real-world human evidence on gut health and body weight.